About Event

The Only Industry-Focused Gene Editing Meeting

The 6th Genome Editing Therapeutics Summit remains the industry’s definitive meeting to enable safer, more precise, and durable edits for a variety of diseases. By showcasing the emerging cutting-edge technologies, whilst also battling the key challenges limiting preclinical and clinical success, we will provide your team with the insights needed to maximize the potential for your therapies.  

Collaborate with senior experts working across discovery, R&D, delivery, preclinical and clinical development, to streamline your end-to-end development. Hear the latest data, from novel technologies and innovative platforms through to the leading clinical programs, to support you in building robust strategies to break new therapeutic ground.  

The 2025 Agenda a Glance – What Not to Miss

Leverage learnings from leading assets to revolutionize next generation approaches and build unbreakable clinical strategies with HuidaGene Therapeutics and Bluebird Bio

Distinguish trailblazing technology platforms and unlock in vivo editing to facilitate editing accessibility and improve therapeutic safety with nChromaBio and Metagenomi

Drive efficient delivery with increased specificity by discussing viral and non-viral approaches to mediate precise targeting with Mammoth Biosciences and nChromaBio

Enhance translatability and boost scalability through biomarker discovery, improved preclinical models and optimized production with Epic Bio, Modalis Therapeutics and Apellis Pharmaceuticals

Discuss approaches to safeguard investment and secure partnerships to accelerate progression from discovery through to commercialization with Prime Medicine, Novartis and Innovative Genomics Institute

"There were notable speakers and topics pertaining to bringing a drug product into clinic and navigating regulatory guidance”

Christie St John, Senior Scientist, Intellia Therapeutics, 2024 Attendee 

Connect with Leading Experts

6th Genome Editing Therapeutics Summit - Companies in the Room 3

I am excited to be a part of this summit, which brings together leading voices in this rapidly evolving field. This meeting provides a timely platform to explore how we can innovate and translate these tools into safe and effective therapies for patients

Anna Gough, Scientist, Tune Therapeutics, 2025 Speaker